Maryland Senate bill in Session 2026.
Status: introduced. Latest action: April 24, 2026.
Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling.
Prohibiting a person from offering for sale in the State a gene structure- or function-modifying product unless the product is labeled in a prominent and conspicuous manner with the words "gene structure- or function-modifying product" and all potential risks, side effects, adverse effects, and other reasonably possible effects that the product may have; and establishing penalties for a violation of the Act.
| Date | Event | Detail |
|---|---|---|
| 2026-01-14 | Introduced | Bill introduced |
| 2026-01-14 | Status | introduced |
| 2026-04-24 | Latest Action | In the Senate - Unfavorable Report by Finance; Withdrawn |